Tylenol with codeine

Phase 2Small molecule

NNational Center for Complementary and Integrative Health (NCCIH)

Tylenol with codeine is one of 15 small molecule programs targeting Neck pain. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Neck PainActive, not recruiting

Neck PainPhase 2

Active, not recruiting

Competition

Competitive Landscape

19 competitors in Neck Pain

#DrugCompanyPhaseTrials

Epidiolex

Advil

3 3

Marcaine

IInnocoll

Approved

1 4

Versed

CConrado Roberto Hoffmann Filho

Oxycontin

Vivarin

HHikma Pharmaceuticals LLC

Phase 3

1 7

Tylenol

KKenvue Brands

Phase 2

1 8

Aspercreme Warming

AAveritas Pharma, Inc.

Phase 2

1 9

Non-Steroidal Anti-Inflammatory Drugs (NSAID)

Roche

Phase 2

1 10

Anjeso

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Neck pain1 trial

Chiropractic Care, Medication, and Self-Care for Neck Pain

Completed·NNational Center for Complementary and Integrative Health (NCCIH)·Phase 2·NCT00029770·270 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tylenol with codeine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tylenol with codeine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tylenol with codeine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Center for Complementary and Integrative Health (NCCIH) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: NNational Center for Complementary and Integrative Health (NCCIH)

Tylenol with codeine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Neck pain1 trial

References

Drug Info

Quick Facts

Related News